Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Ltd has scheduled an Earnings Conference Call for Wednesday, May 20, 2026 at 11:00 AM IST to discuss the Audited Standalone and Consolidated Financial Results for Q4 and the financial year ended March 31, 2026. The call will be hosted by JM Financial Institutional Securities Limited. Key participants from the company include MD & CEO Mr. Ajay Bhardwaj and CFO Mr. Gawir Baig. The company has disclosed dial-in details and a Diamond Pass Link for institutional and retail investor participation. The filing is made pursuant to Regulation 30 read with Schedule III of the SEBI LODR Regulations, 2015.
This is a routine disclosure informing investors of an upcoming earnings call. No direct impact on the stock, but interested investors can participate to gain insights into the company's Q4 and full-year FY2026 financial performance.